1 min read

ID: 355015

Discovery Date: 29 July 2022, 15:12:09 UTC

Published Date: NaT

Source: European Clinical Trials Register

Link: https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-001442-15


EudraCT Number: 2011-001442-15
Sponsor Protocol Number: CFTY720D2324
Sponsor Name: Novartis Pharma Services AG
Start Date: 2011-08-26
Medical condition: relapsing remitting multiple sclerosis
Version: 14.1
SOC Term: 10029205 - Nervous system disorders
Classification Code: 10063399
Term: Relapsing-remitting multiple sclerosis
Level: PT

Population Age: Adults
Gender: Male, Female
Trial Protocol: DE (Prematurely Ended), GB (Completed), ES (Completed), GR (Prematurely Ended), AT (Prematurely Ended), CZ (Completed), FI (Prematurely Ended), HU (Completed), SE (Completed), IT (Prematurely Ended)

Noun Phrases in Title

This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.